The US Food and Drug Administration (USFDA) has successfully completed an inspection at Cadila Healthcare’s Pharmaceutical Technology Centre (PTC) located at Ahmedabad, dedicated to new product development of various niche dosage forms including solid oral, parenteral, pulmonary, oncology, ointment & creams and transdermal, from March 18 to March 22, 2019. At the end of the inspection, no observations (483) have been issued.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
